Blood Oxygen Saturation Articles & Analysis
8 news found
The new “USCOM O2” is the high end of the Uscom technology range and includes direct measurement of blood oxygen saturation generating beat to beat measures of oxygen delivery, a complex and critical measure of cardiovascular performance. ...
In parallel, the company has launched clinical trials to receive regulatory certification for additional vital signs including continuous respiratory rate, core temperature, oxygen saturation, blood pressure, and other arrhythmias. “Following an extensive development process and clinical trials, CardiacSense is the first and only company ...
Raydiant Oximetry has developed a non-invasive fetal pulse oximeter to directly monitor a fetus’s blood oxygen saturation during labor and delivery and provide the key missing vital sign that clinicians need to more accurately assess the baby’s health during childbirth. ...
The company is currently conducting several additional multi-site clinical trials in order to receive regulatory approvals including from Israel’s Ministry of Health including for measuring body temperature, respiratory rate, blood pressure and oxygen saturation (SpO2) in the blood as well as detecting additional arrythmias ...
Among other things, the watch measures respiratory rate, heart rate, blood pressure and blood oxygen saturation and detects cardiac arrhythmias and heart failure at the uniquely precise level equivalent to an ECG. ...
Oxitone's patented, trans-illumination optical technology provides REAL-TIME updates on all vital signs such as, but are not limited to, blood oxygen saturation, pulse rate, skin temperature, and pulse rate variability through our wearable medical-grade wrist-band. ...
CardiacSense’s wristwatch measures, among other indices, body temperature, respiratory rate, heart rate, blood pressure and blood oxygen saturation, and detects cardiac arrhythmias and cardiac arrest at a unique accuracy level equivalent to ECG, and is the only medical wristwatch of its kind which was successfully ...
The company has treated the first patient in trial AKST4290-206 (STEEL) studying the effect of AKST4290 on choroidal blood flow (ChBF) in patients with neovascular age-related macular degeneration (AMD). ...